Skip to main content

Soo-Jeong Cho

Seoul National University · 医学

研究室紹介

Professor Soo-Jeong Cho's research lab specializes in gastrointestinal oncology and molecular gastroenterology, with a focus on the pathogenesis, risk stratification, and therapeutic strategies for gastric and colorectal cancers. The lab investigates molecular mechanisms underlying carcinogenesis, particularly the roles of epigenetic regulators like KMT2C and signaling pathways such as NF-κB in gastric and colon cancer progression. It also explores the impact of medical therapies—such as statins and antiplatelets—on cancer risk and treatment outcomes, integrating translational research with clinical endoscopy and pathology. The lab emphasizes precision medicine through biomarker discovery and validation of staging systems like OLGA and OLGIM for early gastric cancer risk prediction.

gastric cancercolorectal cancerepigeneticsendoscopic treatmentmolecular oncology

Research Overview

Papers
410
Total Citations
6,600
Papers (5y)
119
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
119total
2022
2023
2024
2025
2026
Citations per year (5y)
279total
20222023202420252026

Selected Papers

15
1
Article|197 citations·2008
Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis‐associated colon cancer in mice
Soo‐Jeong Cho, Joo Sung Kim, Joo Sung Kim, Jung Mogg Kim, Jung Mogg Kim, Jong Yeul Lee, Hyun Chae Jung, In Sung Song
SJR Q1International Journal of CancerOA

Statins, HMG-CoA reductase inhibitors could be associated with the risk reduction of colorectal cancer. We previously demonstrated that simvastatin inhibits NF-kappaB signaling in human intestinal epithelial cells and ameliorates acute murine colitis. The aim of our study was to evaluate the effects of simvastatin on the apoptotic pathways related to NF-kappaB signaling in colon cancer cells, and on anticancer effects in 2 different animal models. We treated cell lines (COLO 205 and HCT 116) wit

Cancer ResearchBiochemistry, Genetics and Molecular Biology
2
Article|106 citations·2012
Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms
Soo‐Jeong Cho, In-Hwa Choi, C. Kim, JuHee Lee, Byung Ho Nam, M. Kwak, H. Kim, Keun Won Ryu, JuHee Lee, Young‐Woo Kim
SJR Q1Endoscopy

BACKGROUND AND STUDY AIM: The risk of bleeding after endoscopic submucosal dissection (ESD) in patients with early gastric neoplasms who do not discontinue aspirin for the procedure has not been established. We aimed to investigate whether post-ESD gastric bleeding is increased in patients who take aspirin. PATIENTS AND METHODS: Patients who underwent ESD for early gastric neoplasms at the National Cancer Center Hospital, Korea, between November 2008 and January 2011 were enrolled. The risk of p

Pulmonary and Respiratory MedicineMedicine
3
Article|95 citations·2018
RETRACTED: KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition
Soo‐Jeong Cho, Changhwan Yoon, Jun Ho Lee, Kevin K. Chang, Jian-Xian Lin, Young Ho Kim, Myeong‐Cherl Kook, Bülent Arman Aksoy, Do Joong Park, Hassan Ashktorab, Duane T. Smoot, Nikolaus Schultz
SJR Q1Clinical Cancer ResearchOA

Abstract Purpose: Lauren diffuse-type gastric adenocarcinomas (DGAs) are generally genomically stable. We identified lysine (K)-specific methyltransferase 2C (KMT2C) as a frequently mutated gene and examined its role in DGA progression. Experimental Design: We performed whole exome sequencing on tumor samples of 27 patients with DGA who underwent gastrectomy. Lysine (K)-specific methyltransferase 2C (KMT2C) was analyzed in DGA cell lines and in patient tumors. Results: KMT2C was the most frequen

OncologyMedicine
4
Article|90 citations·2013
Staging of intestinal‐ and diffuse‐type gastric cancers with theOLGAandOLGIMstaging systems
Soo‐Jeong Cho, Il Ju Choi, Myeong‐Cherl Kook, Byung Ho Nam, C. G. Kim, J. Y. Lee, Keun Won Ryu, Young‐Woo Kim
SJR Q1Alimentary Pharmacology & Therapeutics

BACKGROUND: Operative link on gastritis assessment (OLGA) and Operative link on gastric intestinal metaplasia assessment (OLGIM) staging systems have been proposed for gastric cancer (GC) risk estimation. AIM: To validate the OLGA and OLGIM staging systems in a region with high risk of GC. METHODS: This retrospective study included 474 GC patients and age- and sex-matched health screening control persons in a cancer centre hospital. We classified gastritis patterns according to the OLGA and OLGI

SurgeryMedicine
5
Article|89 citations·2011
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification
Soo‐Jeong Cho, Il Ju Choi, Changsoo Kim, J. Lee, Myeong‐Cherl Kook, S. Park, Keun Won Ryu, J. Lee, Young‐Woo Kim
SJR Q1Endoscopy

BACKGROUND AND AIMS: Therapeutic guidelines have not yet been established for low-grade gastric adenomas/dysplasias (LGD), which have a low risk of progression to high-grade adenomas/dysplasias (HGD) or to invasive carcinomas. This study aimed to evaluate risk factors for HGD/carcinoma that indicate a need for resection in biopsy-proven LGD lesions. PATIENTS AND METHODS: In total, 236 LGD lesions from 208 consecutive patients treated with endoscopic resection (ER) were retrospectively studied be

Pulmonary and Respiratory MedicineMedicine
6
Article|87 citations·2007
Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Soo‐Jeong Cho, Jung‐Hwan Yoon, Seung‐Sik Hwang, Hyo‐Suk Lee
SJR Q1Journal of Gastroenterology and Hepatology

BACKGROUND AND AIM: The risk of hepatocellular carcinoma (HCC) is known to be age dependent; the influence of age on prognosis is, however, controversial. The aim of this study was to compare the tumor characteristics and survival rates of young and old HCC patients, with respect to tumor stage. METHODS: We reviewed the clinical data and survival times of 71 young HCC patients from 1987 to 2003 and compared these with those of their older counterparts (n = 239). Patients were categorized into th

HepatologyMedicine
7
Article|77 citations·2018
Body mass index and mortality in patients with gastric cancer: a large cohort study
Jung Hwan Lee, Boram Park, Jungnam Joo, Myeong‐Cherl Kook, Young‐Il Kim, Jong Yeul Lee, Chan Gyoo Kim, Il Ju Choi, Bang Wool Eom, Hong Man Yoon, Keun Won Ryu, Young‐Woo Kim
SJR Q1Gastric CancerOA
Pulmonary and Respiratory MedicineMedicine
8
Article|67 citations·2014
Long‐term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study
Young‐Il Kim, Su‐Young Kim, Soo‐Jeong Cho, Jong‐Ho Park, Il Ju Choi, Y. J. Lee, Eun Kyung Lee, Myeong‐Cherl Kook, C. G. Kim, Keun Won Ryu, Young‐Woo Kim
SJR Q1Alimentary Pharmacology & Therapeutics

BACKGROUND: Metformin use has been associated with a decreased incidence and mortality of various cancers. AIM: To evaluate the association between metformin use and gastric cancer. METHODS: We randomly selected 100 000 type 2 diabetic patients from the 2004 Korean National Health Insurance claim database, and assessed gastric cancer incidence among 39 989 patients (aged 30-97 years) who were regularly treated with anti-diabetic drugs and followed-up from 2004 to 2010. In total, 26 690 patients

Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|66 citations·2014
MicroRNA 135a Suppresses Lymph Node Metastasis through Down-Regulation of ROCK1 in Early Gastric Cancer
Ji-Young Shin, Young‐Il Kim, Soo‐Jeong Cho, Mi Kyung Lee, Myeong‐Cherl Kook, Jun Ho Lee, Sang Soo Lee, Hassan Ashktorab, Duane T. Smoot, Keun Won Ryu, Young‐Woo Kim, Il Ju Choi
SJR Q1PLoS ONEOA

MicroRNAs (miRNAs) play a critical role in gastric cancer progression and metastasis. This study investigated the role of miRNA-135a in early gastric cancer (EGC) including lymph node (LN) metastasis. We examined the correlation between miRNA-135a expression and clinical outcomes in 59 patients who underwent surgery for EGC. Using gastric cancer cell lines, we performed functional and target gene analyses. miRNA-135a expression was down-regulated in 33.9% of patients. These patients showed a sig

Cancer ResearchBiochemistry, Genetics and Molecular Biology
10
Article|65 citations·2006
16S rDNA Analysis of Bacterial Diversity in Three Fractions of Cow Rumen
Soo‐Jeong Cho, Kye Man Cho, Eun Chule Shin, Woo Jin Lim, Su Young Hong, Byoung Rock Choi, Jung Mi Kang, Sun‐Mi Lee, Yong Hee Kim, Hoon Kim, Han Dae Yun
SJR Q2Journal of Microbiology and Biotechnology

The bacterial diversity of the bovine rumen was examined using a PCR-based approach. 16S rDNA sequences were amplified and cloned from three fractions of rumen (solid, fluid, and epithelium) that are likely to represent different bacterial niches. A total of 113 clones were sequenced, and similarities to known l6S rDNA sequences were examined. About of the sequences had similarity to 16S rDNA database sequences. Furthermore, about of the sequences were similar to 16S rDNA database sequences. For

Agronomy and Crop ScienceAgricultural and Biological Sciences
11
Article|46 citations·2013
Randomised clinical trial: the effects ofHelicobacter pylorieradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer
Soo‐Jeong Cho, Il Ju Choi, Myeong‐Cherl Kook, Hong Man Yoon, S. Park, C. G. Kim, J. Y. Lee, J H Lee, Keun Won Ryu, Young‐Woo Kim
SJR Q1Alimentary Pharmacology & Therapeutics

Helicobacter pylori eradication in GC patients is beneficial, as reflected by lower scores of atrophy and IM at 36 months after subtotal gastrectomy. (ClinicalTrials.gov number, NCT01002443).

SurgeryMedicine
12
Article|46 citations·2014
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
Soo‐Jeong Cho, Myeong‐Cherl Kook, Jun Ho Lee, Jiyoung Shin, Juri Park, Young‐Ki Bae, Il Ju Choi, Keun Won Ryu, Young‐Woo Kim
SJR Q1International Journal of Cancer

The importance of PPARγ (peroxisome proliferator-activated receptor γ) in gastric cancer (GC) is unclear. We investigated the role of PPARγ in GC cell lines and an animal model, and its prognostic significance of PPARγ in GC patients. We controlled PPARγ and galectin-9 expression by using siRNAs and lentiviral constructs. Interaction between PPARγ and galectin-9 was evaluated using luciferase and chromatin immunoprecipitation assays. PPARγ expression in GCs was determined by immunohistochemical

ImmunologyImmunology and Microbiology
13
Article|41 citations·2007
The Anti-Cancer Effect of COX-2 Inhibitors on Gastric Cancer Cells
Soo‐Jeong Cho, Nayoung Kim, Joo Sung Kim, Hyun Chae Jung, In Sung Song
SJR Q2Digestive Diseases and Sciences
PharmacologyMedicine
14
Article|37 citations·2019
RETRACTED: CDX1 Expression Induced by CagA-Expressing Helicobacter pylori Promotes Gastric Tumorigenesis
Sang Il Choi, Changhwan Yoon, Mi Ree Park, DaHyung Lee, Myeong‐Cherl Kook, Jian-Xian Lin, Jun Hyuk Kang, Hassan Ashktorab, Duane T. Smoot, Sam S. Yoon, Soo‐Jeong Cho
SJR Q1Molecular Cancer Research

Abstract Intestinal-type gastric cancer often results from Helicobacter pylori infection through intestinal metaplasia, a transdifferentiated premalignant phenotype. Because H. pylori virulence factor CagA has been associated with aberrant expression of the transcription factor CDX1, which regulates intestinal differentiation, we explored its relationship with H. pylori infection and function during gastric carcinogenesis in normal gastric epithelial cells and gastric cancer cell lines. Infectio

GeneticsBiochemistry, Genetics and Molecular Biology
15
Article|35 citations·2012
Argon plasma coagulation is safe and effective for treating smaller gastric lesions with low-grade dysplasia: a comparison with endoscopic submucosal dissection
Se Jin Jung, Soo‐Jeong Cho, Il Ju Choi, Myeong‐Cherl Kook, Chan Gyoo Kim, Jong Yeul Lee, Sook Ryun Park, Jun Ho Lee, Keun Won Ryu, Young‐Woo Kim
SJR Q1Surgical Endoscopy
Pulmonary and Respiratory MedicineMedicine

Research Areas

Pulmonary and Respiratory MedicineSurgeryMolecular BiologyOncologyPharmacologyBiotechnology

Soo-Jeong Choの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。